being representative for absolute bioavailability (true absorption) or for intraindividual variation. Therefore, we investigated the reproducibility of the absolute bioavailability of strontium chloride, a marker for intestinal calcium absorption, in healthy male volunteers (n = 8) by measuring the area under the plasma strontium concentration-time curve after oral and intravenous administration of strontium. Subsequently, we selected a simple test variable as being representative of absolute bioavailability. The mean absolute bioavailability (±SD) was 25% ± 7%. The best test variable appeared to be the fractional absorption at 240 mm (Fc240) after oral intake, which demonstrated the highest correlation with absolute bioavailability (r = 0.66). The intraindividual variations of the data for this variable and for the absolute bioavailability are similar to those described for various absorption tests based on the use of calcium isotopes. Thus, the Fc240 of strontium offers the potential of a simple clinical test for use as a measure of intestinal calcium absorption and its modulation. 
Indexing Terms: pharmacokirietics/metabolism

Data Analysis
In each subject the absolute bioavailability of orally administered strontium chloride was calculated three times. The absolute bioavailability was calculated from the ratio of the area under the plasma concentrationtime curve (AUC#{176}#{176}) after an oral dose (oral) and the AUC#{176}#{176} of the intravenous dose (i.v), with both areas normalized for dose as follows:
oral AUC#{176}#{176}#{176} was calculated on the basis of the trapezoidal rule by use of the computer program Topfit 2.0 (9). Absolute bioavailability assessed in this way can be considered the "gold standard" for determining true intestinal absorption, because the calculated ratio from which the absolute bioavailability is determined corrects for all routes of distribution and excretion. The duration of the sampling time of each test was based on 5 t112 (elimination half-life) (10); i.e., 95% of AUC#{176}is described by the data. Various pharmacokinetic variables were determined for tests 1-3 to select one representative of intestinal absorption. First, we calculated values for the variables described in the literature-i.e., the fractional absorption at 60 mm (Fcm) (11) and at 240 mm (Fc240) (4):
where C = plasma concentration at t minutes, C0 = plasma concentration at 0 min, Vd = volume of distribution represented by 15% of the body weight (BW), and D = dose (2.5 mmol of strontium chloride). Because we expected improvement in precision when using a variable based on more than one concentration, we assessed AUC#{176}#{176} and AUC#{176}24#{176} (AUC over the interval 0-60 and 0-240 mm, respectively). (17) Calcium concentration corrected for the serum albumin concentration. increase with time ( In conclusion, the results of this study make clear that Fc240, measured by only two plasma concentrations, provides reliable information about the absolute bioavailability of strontium and thus indirectly also of calcium. Although the applicability of this variable in patients still needs further investigation, it clearly has the potential to be a simple test that gives information about intestinal calcium absorption and its modulation.
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